![](/img/cover-not-exists.png)
1303TiPRandomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Rohaan, M W, Borch, T H, van den Berg, J H, Geukes Foppen, M H, Donia, M, Met, Ö, Nuijen, B, van Zon, M, Bakker, E A M, de Boer, R, Pronk, L M, Wilgenhof, S, Blank, C U, van Thienen, J V, van Akkooi,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy289.059
Date:
October, 2018
File:
PDF, 78 KB
english, 2018